Applied Biosystems™ resDNASEQ™ Quantitative Plasmid DNA - Kanamycin Resistance Gene Kit

The resDNASEQ Quantitative Plasmid DNA - Kanamycin Resistance Gene Kit is a quantitative PCR (qPCR)-based system for the detection of residual kanamycin-resistant plasmids used in the development of gene therapies, cell-based vaccines, and similar biotherapeutics. Reliable and rapid, the resDNASEQ system enables sensitive and specific quantitation of kanamycin-resistant plasmid DNA. This performance helps ensure a high degree of confidence in quantitation data obtained from a broad range of sample types—from in-process samples with different sample matrices to bulk drug substance.

For use with equipment: Qs5 0.1 mL Block or 7500 FAST

Features

• Designed to quantitate residual plasmid DNA with any common alleles of kanamycin-resistance gene
• Highly sensitive quantitation through innovative DNA-free master mix
• Reliable and specific quantitation using proven TaqMan real-time PCR technology
• Includes master mix, TaqMan primer/probe mix, and kanamycin-resistant plasmid DNA standard